{"id":1880,"date":"2018-06-13T15:13:50","date_gmt":"2018-06-13T13:13:50","guid":{"rendered":"https:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/uncategorized\/achema-2018-a-consistently-positive-interim-conclusion\/"},"modified":"2022-06-17T09:28:19","modified_gmt":"2022-06-17T07:28:19","slug":"achema-2018-a-consistently-positive-interim-conclusion","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/","title":{"rendered":"ACHEMA 2018: A consistently positive interim conclusion"},"content":{"rendered":"<p class=\"p1\"><span class=\"s1\">&#8220;The first three days of the fair were very successful for us. I am very pleased about this,&#8221; said Tim Henrichs, Marketing Manager Europe Chemicals at Yokogawa Germany, after the third day of this year&#8217;s ACHEMA 2018. In addition, this year&#8217;s key theme &#8220;Synaptic Business Automation&#8221; (SBA) has also been well received so far. &#8220;Customers have understood what our intention is and think SBA is a very exciting approach,&#8221; said Henrichs.<\/span><\/p>\n<h3 class=\"p1\"><span class=\"s1\"><img decoding=\"async\" class=\" wp-image-5626 alignleft\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_4667-scaled.jpg\" alt=\"\" width=\"444\" height=\"333\">Fully motivated for the last two days of the fair<\/span><\/h3>\n<p class=\"p1\"><span class=\"s1\">In addition, topics such as Profit Driven Operation, ASI, Plant Security, Digital Twin or Cyber Secured Safety were also very well received by trade fair visitors. &#8220;That makes us want to and motivates us for the remaining two days of ACHEMA,&#8221; said Henrichs.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">This year&#8217;s Ozobot exhibition game was also a complete success on the three kick-off days, with more than 250 visitors already taking part and sending the mini robots across the self-built playing field to win a trip to Tokyo. If you want to participate in the game, you can do so until Friday afternoon at the Yokogawa booth E16 in hall 11.1.<\/span><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"HZasMnJJlk\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/automation-en\/6-minutes-lectures-6-experts-explain-6-topics-in-6-minutes-every-day\/\">6-Minutes-Lectures: 6 experts explain 6 topics in 6 minutes &#8211; every day!<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;6-Minutes-Lectures: 6 experts explain 6 topics in 6 minutes &#8211; every day!&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/automation-en\/6-minutes-lectures-6-experts-explain-6-topics-in-6-minutes-every-day\/embed\/#?secret=eK2eE7Vypp#?secret=HZasMnJJlk\" data-secret=\"HZasMnJJlk\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"4NV0irAdjP\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/optimization-en\/new-operations-solution-yokogawa-introduces-oprex-profit-driven-operation-solution\/\">New operations solution: Yokogawa introduces OpreX Profit driven Operation Solution<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;New operations solution: Yokogawa introduces OpreX Profit driven Operation Solution&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/optimization-en\/new-operations-solution-yokogawa-introduces-oprex-profit-driven-operation-solution\/embed\/#?secret=VxxSBOHWfS#?secret=4NV0irAdjP\" data-secret=\"4NV0irAdjP\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"StKOJzQLVa\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/automation-en\/achema-2018-all-information-about-the-worlds-leading-trade-fair\/\">Achema 2018 &#8211; all information about the world&#8217;s leading trade fair<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Achema 2018 &#8211; all information about the world&#8217;s leading trade fair&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/automation-en\/achema-2018-all-information-about-the-worlds-leading-trade-fair\/embed\/#?secret=EHSEa87pCU#?secret=StKOJzQLVa\" data-secret=\"StKOJzQLVa\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tim Henrichs, Marketing Manager Europe Chemicals at Yokogawa Germany, draws a consistently positive conclusion on the first three days of ACHEMA 2018. <\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/\"> <span class=\"screen-reader-text\">ACHEMA 2018: A consistently positive interim conclusion<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":31,"featured_media":1890,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","footnotes":""},"categories":[53],"tags":[289,114,134,108,139,73,291,292],"coauthors":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.13 (Yoast SEO v20.13) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ACHEMA 2018: A consistently positive interim conclusion - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ACHEMA 2018: A consistently positive interim conclusion\" \/>\n<meta property=\"og:description\" content=\"Tim Henrichs, Marketing Manager Europe Chemicals at Yokogawa Germany, draws a consistently positive conclusion on the first three days of ACHEMA 2018.  ACHEMA 2018: A consistently positive interim conclusion Read More &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-13T13:13:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-17T07:28:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_2930-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Niklas Frielingsdorf\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/\"},\"author\":{\"name\":\"Niklas Frielingsdorf\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f\"},\"headline\":\"ACHEMA 2018: A consistently positive interim conclusion\",\"datePublished\":\"2018-06-13T13:13:50+00:00\",\"dateModified\":\"2022-06-17T07:28:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/\"},\"wordCount\":224,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\"},\"keywords\":[\"ACHEMA\",\"Achema2018\",\"Big data\",\"Communication\",\"Industry 4.0\",\"Safety\",\"SBA\",\"Synaptic business automation\"],\"articleSection\":[\"Automation\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/\",\"name\":\"ACHEMA 2018: A consistently positive interim conclusion - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website\"},\"datePublished\":\"2018-06-13T13:13:50+00:00\",\"dateModified\":\"2022-06-17T07:28:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ACHEMA 2018: A consistently positive interim conclusion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Yokogawa&#039;s Chemical &amp; Pharma Blog\",\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f\",\"name\":\"Niklas Frielingsdorf\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/image\/26bfbff9ac7a54d6fe4079add1304bdc\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g\",\"caption\":\"Niklas Frielingsdorf\"},\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/niklas-frielingsdorf\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ACHEMA 2018: A consistently positive interim conclusion - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/","og_locale":"en_US","og_type":"article","og_title":"ACHEMA 2018: A consistently positive interim conclusion","og_description":"Tim Henrichs, Marketing Manager Europe Chemicals at Yokogawa Germany, draws a consistently positive conclusion on the first three days of ACHEMA 2018.  ACHEMA 2018: A consistently positive interim conclusion Read More &raquo;","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2018-06-13T13:13:50+00:00","article_modified_time":"2022-06-17T07:28:19+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_2930-scaled.jpg","type":"image\/jpeg"}],"author":"Niklas Frielingsdorf","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/"},"author":{"name":"Niklas Frielingsdorf","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f"},"headline":"ACHEMA 2018: A consistently positive interim conclusion","datePublished":"2018-06-13T13:13:50+00:00","dateModified":"2022-06-17T07:28:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/"},"wordCount":224,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization"},"keywords":["ACHEMA","Achema2018","Big data","Communication","Industry 4.0","Safety","SBA","Synaptic business automation"],"articleSection":["Automation"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/","name":"ACHEMA 2018: A consistently positive interim conclusion - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website"},"datePublished":"2018-06-13T13:13:50+00:00","dateModified":"2022-06-17T07:28:19+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/achema-2018-a-consistently-positive-interim-conclusion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/"},{"@type":"ListItem","position":2,"name":"ACHEMA 2018: A consistently positive interim conclusion"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/","name":"Chemical Pharma Blog","description":"Yokogawa&#039;s Chemical &amp; Pharma Blog","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f","name":"Niklas Frielingsdorf","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/image\/26bfbff9ac7a54d6fe4079add1304bdc","url":"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g","caption":"Niklas Frielingsdorf"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/niklas-frielingsdorf\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_2930-scaled.jpg",2560,1920,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_2930-150x150.jpg",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_2930-300x225.jpg",300,225,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_2930-768x576.jpg",768,576,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_2930-1024x768.jpg",1024,768,true],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_2930-1536x1152.jpg",1536,1152,true],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_2930-2048x1536.jpg",2048,1536,true],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/IMG_2930-356x200.jpg",356,200,true]},"uagb_author_info":{"display_name":"Niklas Frielingsdorf","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/niklas-frielingsdorf\/"},"uagb_comment_info":0,"uagb_excerpt":"Tim Henrichs, Marketing Manager Europe Chemicals at Yokogawa Germany, draws a consistently positive conclusion on the first three days of ACHEMA 2018. ACHEMA 2018: A consistently positive interim conclusion Read More &raquo;","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/1880"}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/comments?post=1880"}],"version-history":[{"count":1,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/1880\/revisions"}],"predecessor-version":[{"id":1889,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/1880\/revisions\/1889"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/media\/1890"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/media?parent=1880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/categories?post=1880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/tags?post=1880"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/coauthors?post=1880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}